🇺🇸 FDA
Patent

US 10851088

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

granted A61KA61K9/20A61P

Quick answer

US patent 10851088 (Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production) held by DENALI THERAPEUTICS INC. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K9/20, A61P, A61P25/28